Skip to main content
Erschienen in: BMC Cardiovascular Disorders 1/2017

Open Access 01.12.2017 | Research article

Regional and hospital variations in the extent of decline in the proportion of percutaneous coronary interventions performed for nonacute indications – a nationwide population-based study

verfasst von: Fu-Wen Liang, Tsung-Hsueh Lu, Hsin-Min Wu, Jo-Chi Lee, Wei-Hsian Yin

Erschienen in: BMC Cardiovascular Disorders | Ausgabe 1/2017

Abstract

Background

The volume and percentage of percutaneous coronary interventions (PCIs) performed for nonacute indications have declined in the United States since 2007. However, little is known if similar trends occurred in Taiwan.

Methods

We used data from Taiwan National Health Insurance inpatient claims to examine the regional and hospital variations in the extent of decline in the percentage of nonacute indication PCIs from 2007 to 2012.

Results

The volume of total PCIs persistently increased from 29,032 in 2007 to 35,811 in 2010 and 37,426 in 2012. However, the volume of nonacute indication PCIs first increased from 7916 in 2007 to 9143 in 2009 and then decreased to 8666 in 2012. The percentage of nonacute indication PCIs steadily decreased from 27% in 2007 to 26% in 2009 and then to 23% in 2012, a − 15% change. The extent of decline was largest in the North region (from 27% to 21%, a − 22% change) and least in Kaopin region (from 20% to 18%, a − 13% change). Of the 71 hospitals studied, 14 did not show a decreasing trend. Five of the 14 hospitals even showed an increasing trend, with a percentage change >10% between 2007 and 2012. In 2012, 6 hospitals had a nonacute indication PCI percentage >35%.

Conclusions

In Taiwan, four-fifths of the hospitals showed a decline in the percentage of nonacute indication PCIs from 2007 to 2012. It is plausible that Taiwanese cardiologists would have been influenced by the recommendations of crucial US trials and guidelines.
Abkürzungen
AUC
Appropriate Use Criteria for Coronary Revascularization
CABG
coronary artery bypass grafting
COURAGE
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
ICD-9-CM
International Classification of Disease, Ninth Revision, Clinical Modification
NHI
National Health Insurance
NSTEMI
non-ST-segment elevation myocardial infarction
PCIs
percutaneous coronary interventions
SIHD
stable ischemic heart disease
STEMI
ST-segment elevation myocardial infarction

Background

After the publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial in 2007 and the Appropriate Use Criteria for Coronary Revascularization (AUC) in 2009 [1, 2], the volume and percentage of percutaneous coronary interventions (PCIs) performed for nonacute indications (or stable ischemic heart disease, SIHD) declined prominently in the United States [310]. However, only few studies have further examined the regional and hospital variations in the percentage of PCIs for nonacute indications [5, 9, 10].
Mohan et al. suggested that among hospital referral regions, the variations in the rate of PCIs performed for SIHD declined by 28% after the publication of the COURAGE study, but geographic variations remained higher for SIHD than for acute coronary syndrome [5]. Two studies have revealed that although the overall proportion of nonacute PCIs classified as inappropriate has declined, the hospital-level variations in inappropriate PCIs persist [9, 10].
In the era of globalization and evidence-based medicine, crucial trials and guidelines published in the United States might also have a substantial impact on cardiologists worldwide. However, little is known regarding whether similar trends exist in Taiwan, a country which is on the other side of Pacific Ocean and which has a different healthcare-financing system from that of the United States. In this study, we sought to examine regional and hospital variations in the extent of decline in the proportion of PCIs performed for nonacute indications in Taiwan from 2007 to 2012. Furthermore, professional organizations and insurance payers are eager to know the number and types of hospitals that did not show the expected decreasing trend after the publication of an important trial and guideline in which the assessment of the appropriateness of performed PCIs is considered necessary.

Methods

Data sources

Taiwan National Health Insurance (NHI) inpatient claims data were used for this study. The NHI program was introduced in 1995 and covers more than 99% of the population of Taiwan. Because all patients receiving PCIs in Taiwan were required to be hospitalized for observation, we assessed only the inpatient claims data and not the outpatient claims data. The inpatient claims data comprised data on diagnosis and procedure codes, various service fees, patient characteristics, attending physicians, and hospitals (level of accreditation and ownerships) [11, 12]. This study was approved by the Institutional Review Board of Cheng Hsin General Hospital (CHGH-IRB No. (424)103-1).

PCIs performed

We used International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) procedure codes 36.01, 36.02, 36.05, 36.06, and 36.09, which were recorded in 5 of the discharge procedure columns in the NHI inpatient claims data between January 2007 and December 2012, to identify patients receiving PCIs. Taiwan NHI does not use ICD-9-CM codes 00.66, 36.00, and 36.07 for PCIs, which are used in US hospitals.

Nonacute indications

Crucial information (such as the symptoms and functional assessment of patients and the results of stress testing) required to assess the indications for performed PCIs is not available in the claims data. We could use only the ICD-9-CM codes of 5 discharge diagnoses recorded in the claims data to determine the indications for performed PCIs. The diagnoses classified as acute indications were modified based on the study of Chan et al. [13]: 1) “ST-segment elevation myocardial infarction (STEMI)” if the ICD-9-CM code 410.0, 410.1, 410.2, 410.3, 410.4, 410.5, 410.6, or 410.8 was recorded; 2) “non-ST-segment elevation myocardial infarction (NSTEMI)” if the ICD-9-CM code 410.7 or 410.9 was recorded; 3) “unstable angina” if the ICD-9-CM code 411, 411.0, 411.1, 412, 413.0, 413.1, 414.02, 414.03, 414.04, 411.81, or 411.89 was recorded; 4) “heart failure” if the ICD-9-CM code 428.xx was recorded; 5) “ventricular arrhythmia” if the ICD-9-CM code 427.1 or 427.4 was recorded; and 6) PCI or coronary artery bypass grafting (CABG) surgery received during previous hospitalizations. PCIs performed in the absence of the aforementioned diagnoses were classified as those performed for nonacute indications.

Statistical analyses

First, we determined the number of total and nonacute indication PCIs performed from 2007 to 2012 by region. The six regions defined in this study are similar to hospital referral regions in the United States. In each region, there are several tertiary referral medical centers and people live in the region usually will receiving PCI in hospitals within the region. Second, we used the percentage change [(2007-2012)*100/2007%] between 2007 and 2012 to indicate the extent of decline in the proportion of PCIs for nonacute indications. A box-and-whisker plot was used to present the regional and hospital variations in the extent of decline. Third, we assessed not only the extent of decline but also the absolute number and percentage of nonacute indication PCIs performed in the latest available year (ie, 2012 for this study). This information is key to determining the priority for further assessment or intervention.
Fourth, we compared the characteristics of hospitals with a different extent of decline in the percentage of nonacute indication PCIs. The cut points of tertile of percentage change of 71 hospitals was −30% and −6%. Hospitals with a percentage change of lower than −30% were classified as the largest decline group, between −30% and −6% as the moderate decline group, and higher than −6% as the least decline group. The hospital characteristics were the accreditation level (tertiary referral medical center vs. secondary referral hospital), ownership (public vs. private) volume of PCIs performed in 2007, and the location (region). The chi-square test was used to examine if the distribution of characteristics differed by the extent of decline. If the number of hospitals in one cell was less than 5, Fisher’s exact test was used.
Fifth, to examine if the decline of nonacute indication was associated the higher use of coronary angiography. Pearson correlation was used to examine the association between hospital percentage change in number of coronary angiography between 2007 and 2012 and hospital percentage change in decline of nonacute indication PCIs.

Results

A total of 205,834 PCIs were performed in Taiwan between January 2007 and December 2012. The volume of total PCIs performed persistently increased from 29,032 in 2007 to 35,811 in 2010 and 37,426 in 2012 (Table 1). However, the volume of nonacute indication PCIs first increased from 7916 in 2007 to 9143 in 2009 and then decreased to 8666 in 2012. The percentage of nonacute indication PCIs persistently decreased from 27% in 2007 to 26% in 2009 and then 23% in 2012.
Table 1
Number and percentage (%) of nonacute PCIs from 2007 to 2012 in Taiwan by region
 
2007
2008
2009
2010
2011
2012
% change*
Taiwan
 Non-acute PCI
7916
8420
9143
8725
8519
8666
9.5
 Total PCI
29,032
32,074
35,219
35,811
36,272
37,426
28.91
 %
27.3
26.3
26.0
24.4
23.5
23.2
−15.1
Taipei
 Non-acute PCI
3497
3679
4154
3780
3910
3773
7.9
 Total PCI
10,756
11,441
12,822
12,567
12,985
12,905
20.0
 %
32.5
32.2
32.4
30.1
30.1
29.2
−10.1
North
 Non-acute PCI
845
783
866
965
898
847
0.2
 Total PCI
3133
3260
3723
3935
3851
4033
28.7
 %
27.0
24.0
23.3
24.5
23.3
21.0
−22.1
Central
 Non-acute PCI
1533
1677
1716
1699
1584
1710
11.5
 Total PCI
5617
6575
6739
7108
7139
7472
33.0
 %
27.3
25.5
25.5
23.9
22.2
22.9
−16.1
South
 Non-acute PCI
1144
1214
1394
1310
1131
1179
3.1
 Total PCI
4793
5218
6072
6082
5731
6001
25.2
 %
23.9
23.3
23.0
21.5
19.7
19.6
−17.7
Kaopin
 Non-acute PCI
780
929
900
811
849
1036
32.8
 Total PCI
3900
4489
4816
4961
5516
5930
52.1
 %
20.0
20.7
18.7
16.3
15.4
17.5
−12.6
East
 Non-acute PCI
117
138
113
160
147
121
3.4
 Total PCI
833
1091
1047
1158
1050
1085
30.3
 %
14.0
12.6
10.8
13.8
14.0
11.2
−20.6
* % change = (2012-2007)*100/2007
Regarding regional variation, in 2007, the percentage ranged from 19% in the Kaopin and East region to 33% in the Taipei region. In 2012, the percentage ranged from 18% in the Kaopin region to 29% in the Taipei region (Table 1). The extent of decline was largest in the North region (from 27% in 2007 to 21% in 2012, a − 22% change) and least in the Kaopin region (from 20% in 2007 to 18% in 2012, a − 13% change).
Regarding hospital variation, we studied only 71 hospitals that performed at least 30 PCIs per year during the study period. There were two hospitals in 2007 and four hospitals in 2012 the annual PCIs performed was less than 30. Of the 71 hospitals, 57 showed a decreasing trend (i.e., the percentage change between 2007 and 2012 was negative; Fig. 1). Of the 14 hospitals that did not show a decreasing trend, 5 had a percentage difference of larger than 10% between 2007 and 2012. The interquartile range of percentage change between 2007 and 2012 was −0.9% to −33.4% in the Taipei region, −21.3% to −44.2% in the North region, −1.9% to −36.4% in the Central region, −5.0% to −28.0% in the South region, and 2.3% to −30.5% in the Kaopin region, and −4.4% to −57.1% in the South region. All hospitals in the North region showed decreasing trends. The hospital variation in the extent of decline was smallest in the South region.
In Fig. 2, we present both the percentage change between 2007 and 2012 and the percentage of nonacute indication PCIs in 2012 by hospital and region. The percentage of nonacute indication PCIs in 2012 was higher than 35% for 6 hospitals, and 5 of these hospitals were in the Taipei region and had a relatively large volume of performed PCIs. Furthermore, in 4 hospitals, the percentage of nonacute indication PCIs was between 30% and 35% in 2012, and these hospitals conducted more than 250 nonacute indication PCIs.
Despite no significant difference in the characteristics of hospitals with variations in the extent of decline, secondary referral hospitals showed the largest extent of decline compared with their counterpart hospitals (Table 2). No significant association between percentage change of performing coronary angiography between 2007 and 2012 and percentage change of nonacute indication PCIs between 2007 and 2012.
Table 2
Characteristics of hospitals with different extents of decline in nonacute PCIs from 2007 to 2012 in Taiwan
 
Total
Largest decline
Moderate decline
Least decline
 
 
No
%
No
%
No
%
No
%
p value*
Level of hospital
        
0.368
 Tertiary referral medical center
17
24
4
17
5
21
8
35
 
 Secondary referral hospital
54
76
20
83
19
79
15
65
 
Ownership of hospital
        
0.762
 Public
21
30
6
25
7
29
8
35
 
 Private
50
70
18
75
17
71
15
65
 
Volume of total PCI in 2007
        
0.959
 High (>384)
28
39
8
33
10
42
10
43
 
 Moderate (170-384)
22
31
8
33
7
29
7
30
 
 Low (<170)
21
30
8
33
7
29
6
26
 
Region
        
0.900
 Taipei
21
30
7
29
6
25
8
35
 
 North
9
13
5
21
3
13
1
4
 
 Central
15
21
5
21
6
25
4
17
 
 South
13
18
3
13
5
21
5
22
 
 Kaupin
10
14
3
13
4
17
4
17
 
 East
2
3
1
4
0
0
1
4
 
Total
71
100
24
100
24
100
23
100
 
*Chi-square test

Discussion

The findings of this study indicate that despite the persistent increase in the volume of total PCIs performed from 2007 to 2012 in Taiwan, the percentage of PCIs performed for nonacute indications steadily decreased from 2007 to 2012, after the publication of the COURAGE trial in 2007 and the AUC guideline in 2009 in the United States. Approximately four-fifths of the studied hospitals showed a decreasing trend in the percentage of nonacute indication PCIs. However, a small number of hospitals still showed an increasing trend and a relatively high percentage of nonacute indication PCIs in 2012.
The persistent increase in the volume of total PCIs performed from 2007 to 2012 in Taiwan was due to the surge in the number of hospitals offering PCIs as a response to the government-initiated Door-to-Balloon Alliance in 2008, which was introduced to improve the survival rate of patients with STEMI, especially in remote areas [11]. Furthermore, the overall PCI utilization rate in Taiwan was 2056 per million adults in 2012, which was almost half of the utilization rate in the United States (3667 per million adults in 2007-2008) [14]. The momentum of increase in the PCI utilization rate in Taiwan may not yet have reached the peak. In addition, even studies in Korea (from 2006 to 2010) and Ireland (from 2004 to 2011) did not show any signs of decrease in PCI utilization [15, 16].
Although the volume of total PCIs persistently increased from 2007 to 2012, we noted a decrease in the volume and percentage of nonacute indication PCIs from 2009 and 2007, respectively, which is similar to the trends noted in the United States [310]. In the era of globalization and evidence-based medicine, cardiologists in Taiwan regularly read American journals and attend meetings in the United States; thus, the practice behaviors of these cardiologists would certainly have been influenced by the recommendations of crucial US trials and guidelines.
However, we could not rule out the possibility that the decline in the proportion of nonacute indication PCIs might be a result of physicians’ upcoding of the severity of diagnoses to justify the appropriateness of performing PCI. One US study has indicated that providers become increasingly aware of the clinical determinants of PCI appropriateness, and the pressure to reduce inappropriate use of PCI mounts may motivate physicians to initiate antianginal medications immediately before PCI, without an adequate interval to assess for response, or they may upcode patient-reported symptoms to influence apparent appropriateness [17]. Moreover, cardiac biomarkers, particularly cardiac troponin I, were used more frequently after 2003. The changing biomarker use is likely to have increased the detection rate of smaller infarcts and thus have predominantly influenced the rates of NSTEMI detection in Taiwan over time, suggesting that the expanded use of troponin testing may artificially alter the incidence rates of acute myocardial infarction and the coding of acute indications for PCIs [12].
Despite the overall decline in the proportion of PCIs for nonacute indications, regional and hospital variations still existed with the extent of decline in the percentage of nonacute indication for PCIs performed both in 2007 and 2012. Obviously, PCI practice patterns vary across regions (Fig. 2). The unique nonacute indication PCI practice profile of each region in Taiwan connotes the concept of a “surgical signature,” proposed by John Wennberg. This signature denotes a unique pattern for the utilization of common surgical procedures in different hospital referral regions [18]. In each regional signature, the rates of some procedures exceed the state (or national) average, whereas other procedures fall below the average. Contrasting signatures are noted in the Taipei and South regions (Fig. 2). In 2012, the percentage of nonacute indication PCIs was higher than 35% in 5 of 21 hospitals in the Taipei region and in none in the South region. In addition, 3 of 21 hospitals in the Taipei region showed a percentage change larger than 10%, but no hospitals in the South region showed a similar large increasing trend.
One possible explanation of the regional “PCI signature” is that local cardiovascular interventionists shared similar opinions on patient selection for PCIs. After the observation of a contrasting “surgical signature” between Boston and New Haven in the 1980s [19], Wennberg interviewed physicians in both regions and learned that “the low rate of carotid endarterectomy rates in New Haven compared with that in Boston could be attributed to a group of skeptical neurologists who simply did not believe in the procedure, preferring aspirin to surgery for any patient who came to them for advice. By contrast, the physicians in Boston had, on average, greater ‘faith’ in carotid artery surgery (although relative to many other parts of the country, the Boston rates were rather low). The conservative medical management of coronary artery disease and symptoms of menopause were more popular in Boston, whereas clinicians in New Haven more often preferred surgical management, which meant that more CABG and hysterectomies were performed. On the other hand, New Haven physicians were more enthusiastic about the conservative management of arthritis of the hip [18, pp. 58-59].”
From the point of view of professional organizations and insurance payers, the identification of hospitals that did not follow the general decreasing trend of hospitals with relatively high proportions of nonacute indication PCIs is important. In 2012, 5 hospitals showed percentage differences of larger than 10% and 6 showed nonacute indication PCI percentages higher than 35%; most of these were hospitals with high volumes in the Taipei region. One possible explanation was that many patients with difficult nonacute indications were referred to these high-volume hospitals from moderate- or low-volume hospitals. Another possible explanation was the high concentration of hospitals in the Taipei region, which led to sharing of the amount of acute indication cases, thereby resulting in a compensatory increase in the proportion of nonacute indication PCIs.
With regard to some hospitals showing trends that were contrary to general trends, Bradley et al. assessed the appropriateness of PCIs performed in Washington State and noted that hospitals in the tertile with the least improvement in the proportion of inappropriate PCIs had a temporal increase in the proportion of inappropriate PCIs from 12% in 2010 to 20% in 2013 [9]. The authors suggested that additional qualitative studies on hospitals with increasing proportions of inappropriate PCIs may serve to validate the patient selection processes.
The strengths of this study were the nationwide population-based design, which included all PCI cases in Taiwan and used strict inclusion criteria for acute indications to define nonacute indications. Nevertheless, our findings should be interpreted in light of the following limitations. First, information on the severity of symptoms, functional assessment, and results of stress testing were not available in the claims data; therefore, we could not accurately assess the indications and the appropriateness of performed PCIs.
Second, only 5 discharge diagnoses were available in the inpatient claims data released for research, and the data of some patients with acute indication ICD-9-CM codes might have been recorded in the sixth or later columns of the discharge diagnosis section. These cases might have been misclassified as those with nonacute indications. In addition, some patients with heart failure might be chronic instead of acute. However, the number of these misclassifications is likely small because most acute indication-related diagnoses would be placed in the first 5 discharge diagnosis columns.
Third, as previously discussed, we could not rule out the possibility that PCI operators might have upcoded the severity of the diagnosis to justify the appropriateness of performing PCIs. Fourth, on the contrary, according to our previous study [12], some coders might have undercoded unstable angina, resulting in the misclassification of an acute indication as a nonacute indication.

Conclusions

This study indicates that approximately four-fifths of the studied hospitals in Taiwan showed a decline in the proportion of PCIs performed for nonacute indications; this trend might have been a result of the publication of the COURAGE study in 2007 and the AUC guideline in 2009. It is plausible that Taiwanese cardiologists are influenced by crucial trials and guidelines published in the United States.
However, a small number of hospitals still did not show decreasing trends after 2007 and showed a relatively high percentage of indication PCIs in 2012. Professional organizations and insurance payers should assessment of the appropriateness of PCIs performed in these hospitals. Furthermore, it is important to remind the physician to carefully assess the risk of patients with stable coronary disease before performing PCI. A systematic review suggests that ejection fraction, sex, diabetes mellitus, previous MI, and CRP independently predicted an increased risk of cardiovascular events and can help identify patients in need of further angiographic investigation [20].

Acknowledgements

This study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health and managed by National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of National Health Insurance Administration, Department of Health or National Health Research Institutes.

Funding

None.

Availability of data and materials

Data and materials are available upon written request to the corresponding author.

Authors’ contributions

Conception and design of study: THL and WHY; Data extraction, management, and analysis: FWL, HMW, and JCL; result interpretation and manuscript drafting/editing: FWL and THL; critical revision for important intellectual content: THL and WHY. All authors read and approved the final manuscript

Competing interests

The authors declare that they have no competing interests.
Not applicable.
The institutional review board of National Cheng Kung University Hospital approved this study and waived the signed consent as all patient data were deidentified (A-ER-104-190).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.CrossRefPubMed Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.CrossRefPubMed
2.
Zurück zum Zitat Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization: a report by the American College of Cardiology Foundation appropriateness criteria task force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2009;53:530–53.CrossRefPubMed Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization: a report by the American College of Cardiology Foundation appropriateness criteria task force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2009;53:530–53.CrossRefPubMed
3.
Zurück zum Zitat Riley RF, Don CW, Powell W, Maynard C, Dean LS. Trends in coronary revascularization in the United States from 2001 to 2009: recent decline in percutaneous coronary intervention volumes. Circ Cardiovasc Qual Outcomes. 2011;4:193–7.CrossRefPubMedPubMedCentral Riley RF, Don CW, Powell W, Maynard C, Dean LS. Trends in coronary revascularization in the United States from 2001 to 2009: recent decline in percutaneous coronary intervention volumes. Circ Cardiovasc Qual Outcomes. 2011;4:193–7.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Ahmed B, Dauerman HL, Piper WD, Robb JF, Verlee MP, Ryan TJ, et al. Recent changes in practice of elective percutaneous coronary intervention for stable angina. Circ Cardiovasc Qual Outcomes. 2011;4:300–5.CrossRefPubMed Ahmed B, Dauerman HL, Piper WD, Robb JF, Verlee MP, Ryan TJ, et al. Recent changes in practice of elective percutaneous coronary intervention for stable angina. Circ Cardiovasc Qual Outcomes. 2011;4:300–5.CrossRefPubMed
5.
Zurück zum Zitat Mohan AV, Fazel R, Huang PH, Shen YC, Howard D. Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trail. Circ Cardiovasc Qual Outcomes. 2014;7:125–30.CrossRefPubMed Mohan AV, Fazel R, Huang PH, Shen YC, Howard D. Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trail. Circ Cardiovasc Qual Outcomes. 2014;7:125–30.CrossRefPubMed
6.
Zurück zum Zitat Howard DH, Shen YC. Trends in PCI volume after negative results from the COURAGE trial. Health Serv Res. 2014;49:153–70.CrossRefPubMed Howard DH, Shen YC. Trends in PCI volume after negative results from the COURAGE trial. Health Serv Res. 2014;49:153–70.CrossRefPubMed
7.
Zurück zum Zitat Kim LK, Feldman DN, Swaminathan RV, Minutello RM, Chanin J, Yang DC, et al. Rate of percutaneous coronary intervention for the management of acute coronary syndrome and stable coronary artery disease in the United States (2007 to 2011). Am J Cardiol. 2014;114:1003–10.CrossRefPubMed Kim LK, Feldman DN, Swaminathan RV, Minutello RM, Chanin J, Yang DC, et al. Rate of percutaneous coronary intervention for the management of acute coronary syndrome and stable coronary artery disease in the United States (2007 to 2011). Am J Cardiol. 2014;114:1003–10.CrossRefPubMed
8.
Zurück zum Zitat Bangalore S, Gupta N, Genereux P, Guo Y, Pancholy S, Feit F. Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: insight from over 8.1 million percutaneous coronary interventions. Int J Cardiol. 2015;183:6–10.CrossRefPubMed Bangalore S, Gupta N, Genereux P, Guo Y, Pancholy S, Feit F. Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: insight from over 8.1 million percutaneous coronary interventions. Int J Cardiol. 2015;183:6–10.CrossRefPubMed
9.
Zurück zum Zitat Bradley SM, Bohn CM, Malenka DJ, Graham MM, Bryson CL, McCabe JM, et al. Temporal trends in percutaneous coronary intervention appropriateness: insights from the clinical outcomes assessment program. Circulation. 2015;132(1):20–6.CrossRefPubMed Bradley SM, Bohn CM, Malenka DJ, Graham MM, Bryson CL, McCabe JM, et al. Temporal trends in percutaneous coronary intervention appropriateness: insights from the clinical outcomes assessment program. Circulation. 2015;132(1):20–6.CrossRefPubMed
10.
Zurück zum Zitat Desai NR, Bradley SM, Parzynski CS, Nallamothu BK, Chan PS, Spertus JA, et al. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA. 2015;314:2045–53.CrossRefPubMedPubMedCentral Desai NR, Bradley SM, Parzynski CS, Nallamothu BK, Chan PS, Spertus JA, et al. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA. 2015;314:2045–53.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Lu TH, Huang YT, Lee JC, Yang LT, Liang FW, Yin WH, et al. Characteristics of early and late adopting hospitals providing percutaneous coronary intervention in Taiwan. J Am Heart Assoc. 2015;4:e002840.CrossRefPubMedPubMedCentral Lu TH, Huang YT, Lee JC, Yang LT, Liang FW, Yin WH, et al. Characteristics of early and late adopting hospitals providing percutaneous coronary intervention in Taiwan. J Am Heart Assoc. 2015;4:e002840.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Yin WH, Lu TH, Chen KC, Cheng CF, Lee JC, Liang FW, et al. The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15 years in a Taiwanese population. Int J Cardiol. 2016;209:103–13.CrossRefPubMed Yin WH, Lu TH, Chen KC, Cheng CF, Lee JC, Liang FW, et al. The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15 years in a Taiwanese population. Int J Cardiol. 2016;209:103–13.CrossRefPubMed
13.
Zurück zum Zitat Chan PS, Patel MR, Klein LW, Krone RJ, Dehmer GJ, Kennedy K, et al. Appropriateness of percutaneous coronary intervention. JAMA. 2011;306:53–61.PubMed Chan PS, Patel MR, Klein LW, Krone RJ, Dehmer GJ, Kennedy K, et al. Appropriateness of percutaneous coronary intervention. JAMA. 2011;306:53–61.PubMed
14.
Zurück zum Zitat Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Coronary revascularization trends in the United States, 2001-2008. JAMA. 2011;305:1769–76.CrossRefPubMedPubMedCentral Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Coronary revascularization trends in the United States, 2001-2008. JAMA. 2011;305:1769–76.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Choi YJ, Cho SJ, Cho J, Cho J, Sohn J, Cho SK, et al. Changes in the practice of coronary revascularization between 2006 and 2010 in the Republic of Korea. Yonsei Med J. 2015;56:895–903.CrossRefPubMedPubMedCentral Choi YJ, Cho SJ, Cho J, Cho J, Sohn J, Cho SK, et al. Changes in the practice of coronary revascularization between 2006 and 2010 in the Republic of Korea. Yonsei Med J. 2015;56:895–903.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Jennings S, Bennett K, Shelley E, Kearney P, Daly K, Fennell W. Trends in percutaneous coronary intervention and angiography in Ireland, 2004-2011:implications for Ireland and Europe. IJC Heart Vess. 2014;4:35–9.CrossRef Jennings S, Bennett K, Shelley E, Kearney P, Daly K, Fennell W. Trends in percutaneous coronary intervention and angiography in Ireland, 2004-2011:implications for Ireland and Europe. IJC Heart Vess. 2014;4:35–9.CrossRef
17.
Zurück zum Zitat Bradley SM, Maynard C, Bryson CL. Appropriateness of percutaneous coronary interventions in Washington state. Circ Cardiovasc Qual Outcomes. 2012;5:445–53.CrossRefPubMed Bradley SM, Maynard C, Bryson CL. Appropriateness of percutaneous coronary interventions in Washington state. Circ Cardiovasc Qual Outcomes. 2012;5:445–53.CrossRefPubMed
18.
Zurück zum Zitat Wennberg JE. Tracking medicine: a researcher’s quest to understand health care. New York: Oxford University Press; 2010. Wennberg JE. Tracking medicine: a researcher’s quest to understand health care. New York: Oxford University Press; 2010.
19.
Zurück zum Zitat Wennberg JE, Freeman JL, Culp WJ. Are hospital services rationed in new heaven or over-utilized in Boston? Lancet. 1987;i(8543):1185-1188. Wennberg JE, Freeman JL, Culp WJ. Are hospital services rationed in new heaven or over-utilized in Boston? Lancet. 1987;i(8543):1185-1188.
20.
Zurück zum Zitat Barbero U, D’Ascenzo F, Nijhoff F, Moretti C, Biondi-Zoccai G, Mennuni M, et al. Assessing risk in patients with stable coronary disease: when should we intensity care and follow-up? Results from a meta-analysis of observational studies of COURAGE and FAME era. Scientifica. 2016;2016:3769152. doi:10.1155/2016/3769152. Barbero U, D’Ascenzo F, Nijhoff F, Moretti C, Biondi-Zoccai G, Mennuni M, et al. Assessing risk in patients with stable coronary disease: when should we intensity care and follow-up? Results from a meta-analysis of observational studies of COURAGE and FAME era. Scientifica. 2016;2016:3769152. doi:10.​1155/​2016/​3769152.
Metadaten
Titel
Regional and hospital variations in the extent of decline in the proportion of percutaneous coronary interventions performed for nonacute indications – a nationwide population-based study
verfasst von
Fu-Wen Liang
Tsung-Hsueh Lu
Hsin-Min Wu
Jo-Chi Lee
Wei-Hsian Yin
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
BMC Cardiovascular Disorders / Ausgabe 1/2017
Elektronische ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-017-0592-4

Weitere Artikel der Ausgabe 1/2017

BMC Cardiovascular Disorders 1/2017 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.